[Abstract] Modern triple quadrupole mass spectrometers provide the ability to detect and quantify a large number of metabolites using tandem mass spectrometry (MS/MS). Liquid chromatography (LC) is advantageous, as it does not require derivatization procedures and a large diversity in physiochemical characteristics of analytes can be accommodated through a variety of column chemistries. Recently, the comprehensive optimization of LC-MS metabolomics using design of experiments (COLMeD) approach has been described and used by our group to develop robust LC-MS workflows (Rhoades and Weljie, 2016). The optimized LC-MS/MS method described here has been utilized extensively for metabolomics analysis of polar metabolites. Typically, tissue or biofluid samples are extracted using a modified BlighDyer protocol (Bligh and Dyer, 1959; Tambellini et al., 2013) . The protocol described herein describes this workflow using targeted polar metabolite multiple reaction monitoring (MRM) from tissues and biofluids via ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). This workflow has been utilized extensively for chronometabolic analysis , with applications generalized to other types of analyses as well Sivanand et al., 2017) . . Within mass spectrometry, various approaches are available, however a rapid approach to profile the global metabolome is needed (Lv et al., 2011; Rhoades and Weljie, 2016) . Advancements in triple quadrupole mass spectrometers have made them well suited for ion-switching methods (scanning in both positive and negative ion modes within a single analysis) in addition to enabling reproducible and sensitive targeted profiling of numerous metabolites (Lv et al., 2011; Gika et al., 2012; Yuan et al., 2012; Rhoades and Weljie, 2016) . Additionally, LC typically does not require extensive sample preparation,
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Procedure
A. Extracting polar metabolites
Polar metabolites were extracted using a modified Bligh-Dyer protocol as described below (Bligh and Dyer, 1959; Tambellini et al., 2013) . Extractions were performed on ice unless otherwise indicated.
1. One set of 1.5 ml microfuge tubes for the collection of polar metabolites should be labeled for each sample. (A second set can be labeled if collection of the nonpolar metabolites is desired as well.) The number of biological replicates required for analysis is dependent upon the study and can range from as few as 5 for highly controlled models to several hundred to thousands for human studies.
2. The following solvents should be prepared and cooled prior to beginning the extraction protocol: a. 2:1 Methanol:Chloroform mixture (300 μl per sample) b. Pure methanol (100 μl per sample) c. Water (18 mΩ, 0.22 μm filtered) (100 μl per sample) 3. Centrifuge should also be cooled to 4 °C. 4 . Samples (i.e., U2OS and primary hepatocyte cell pellets [number of cells equivalent to a 50 mg cell pellet] or 50 mg of liver tissue) should be placed on ice to thaw. i.
Notes
To each sample, 300 μl of the cold 2:1 Methanol:Chloroform mixture is added.
ii. Each microfuge tube containing the sample is vortexed until a homogenous mixture is formed. Figure 1A shows a representative endpoint.
Note: The cell pellet may not be homogenized upon vortexing and thus it is essential to sonicate the sample.
iii. Next, the samples are sonicated in a bath sonicator for 15 min at 35 kHz. Figure 1B shows a representative endpoint.
iv.
At the end of sonication, samples are placed back on ice. (2) layers are shown at the end of centrifugation (Steps A10 to A11).
b. Extraction of tissue using the TissueLyser II:
i. Pre-cool tissue homogenizer blocks by placing at -80 °C.
ii.
To each tissue sample, carefully add a stainless steel bead followed by 300 μl of the cold 2:1 Methanol:Chloroform mixture.
iii. Next, using the pre-cooled blocks (handle using gloves), homogenize the tissue samples at 25 Hz for 4 min using the TissueLyser II.
iv. At the end of homogenization, place the samples back on ice.
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC. 12. The microfuge tubes containing the aqueous layer metabolites are then dried in a speed vacuum for 4 h or until dry.
13. Upon completion of drying, metabolites can either be re-suspended as indicated below or stored at -80 °C.
Note: Storing dried samples at -80 °C impacts the stability of metabolites in a differential manner dependent on various compound classes, therefore, it is recommended to perform LC-MS
analysis soon after extraction.
B. Re-suspending and preparing polar metabolites for LC-MS 1. A randomized run order should be generated in order to minimize variation as a result of sample preparation order.
2. A minimum of 5 blanks in addition to 10 equilibration (EQ) samples will be run at the beginning of the analysis (see Step B13 in this section for information on preparing EQ and QC samples).
Next, 4 quality control (QC) samples will be run followed by the samples. Every 6 to 10 samples, a QC will be run in addition to 2 QC's at the end of the analysis (Figure 2 ). Note that the spacing between QC injections can vary, and may be dependent on sample quantity. Greater QC frequency (e.g., every 6 samples) provides more robust data correction, however requires more sample.
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6 www.bio-protocol.org/e2715 Figure 2 . An example of a sample run order is shown. At least 5 blanks (blue) followed by 10 equilibration samples (green) should be run at the start of an analysis. This is followed by 4 quality control samples (red), samples to be analyzed (purple), and then 2 quality control samples again at the end. The example shows a quality control sample run every 6 samples throughout the analysis, however, this can vary from every 6 to 10 samples.
3. Diluent consisting of 1:1 Acetonitrile:Water should be prepared and cooled beforehand.
4. In addition, the centrifuge should be cooled to 4 °C.
5. Dried polar metabolites, diluent as well as sample tray(s) should be placed on ice.
6. 100 μl of diluent are added to each microfuge tube containing the dried polar metabolites as well as to an empty microfuge tube to be used as a blank. Again, the volume metabolites are resuspended in is dependent on the sample concentration and is adjusted to ensure metabolites are detected within a linear range. Proper dilution of metabolites also ensures longer column life.
7. Each microfuge tube is then vortexed for a minimum of 20 sec in order to re-suspend the metabolites. www.bio-protocol.org/e2715 10. LC-MS vials are placed in sample tray(s) according to a pre-randomized run order.
11. 90 μl of the blank (or volume sufficient for the number of blanks to be run) is added to an LC-MS vial and placed in the sample tray.
12. Once all samples have been aliquoted, the pooled QC sample is vortexed to ensure homogeneity.
13. From the pooled QC sample:
a. An equilibration sample is prepared by diluting the QC sample 10 fold using the diluent (1:1
Acetonitrile:Water).
b. 20 μl is added to mass spec vials and vials are placed in the appropriate positions in the sample tray(s). (The number of vials is dependent on total QC samples to be run and the volume added to vials varies based on desired injection volume.)
14. 90 μl of the EQ sample is added to an LC-MS vial and placed in the sample tray. Volume can be adjusted based on the number of EQ's to be run.
C. Acquiring data by UPLC-MS
Polar metabolites were then analyzed through UPLC-MS utilizing a method optimized through the COLMeD approach as described in (Rhoades and Weljie, 2016 ). The following procedure should be used as guidelines in acquiring data by individuals trained in using a mass spectrometer.
1. Solvent A is prepared fresh according to Recipe 1. In addition, ensure that there is enough of solvent B (Recipe 2) and the seal wash (Recipe 3) present. If not prepare the solvents.
2. An XBridge BEH Amide column (2.5 μm 100 x 2.1 mm) with a pre-column inline filter and vanguard is utilized at a temperature of 40 °C. The column is utilized on an Acquity (H-Class)
UPLC System coupled to a Waters Xevo Triple quadrupole mass spectrometer. Table 2 and are utilized for both electrospray positive and negative modes. Table S1 . We also strongly recommend that any results be validated by inclusion of a stable-isotope labeled internal standard prior to extraction or unlabeled standard analyzed in a similar matrix to confirm retention times and fragmentation patterns.
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